Long Liu

8PUBLICATIONS

29CO-AUTHORS

Predictive and prognostic markersCancer geneticsMajor global burdens of diseaseImmunogenetics (incl. genetic immunology)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 08, 2026

Macrophage-Induced Senescent Cancer-Associated Fibroblasts Promote SASP-Mediated Chemoresistance in Colorectal Cancer.

|Jun 03, 2025

Genome-Scale CRISPR-Cas9 Analysis Reveals Tumor Heterogeneity and Identifies NDC80 as Novel Biomarker in HCC.

Zhipu Liu, Long Liu, Shutong Liu

|Dec 08, 2023

Associations Between Life's Essential 8 and Chronic Kidney Disease.

Yuqing Ren, Zongao Cai, Chunguang Guo

|Nov 22, 2023

AARS2 as a novel biomarker for prognosis and its molecular characterization in pan-cancer.

Long Liu, Jie Gao, Xudong Liu

|Apr 12, 2023

LATS-regulated nuclear-cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial-mesenchymal transition.

Feng Zhang, Jie Gao, Xudong Liu

|Jul 21, 2021

CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis.

Libo Wang, Zaoqu Liu, Long Liu

Pageof 2

Frequent Collaborators

Xinwei Han

Zaoqu Liu

Libo Wang

Yuyuan Zhang

Jie Zhao

Yuling Sun

Ji Hua Shi

Shuijun Zhang

Zongao Cai

Guojun Zhang

Frequent Collaborators

Xinwei Han

Zaoqu Liu

Libo Wang

Yuyuan Zhang